SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025
SI-BONE (Nasdaq: SIBN), a medical device company focused on sacropelvic disorders, has scheduled its first quarter 2025 financial results announcement for May 5, 2025, after market close. The company will hold a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results.
Investors can participate in the conference call by registering through the provided link. The webcast will be accessible through the company's website's 'Investors' section and will remain available for replay for at least 90 days following the event.
SI-BONE (Nasdaq: SIBN), un'azienda di dispositivi medici specializzata nei disturbi sacropelvici, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 5 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call alle 13:30 ora del Pacifico / 16:30 ora dell'Est lo stesso giorno per discutere i risultati.
Gli investitori possono partecipare alla conference call registrandosi tramite il link fornito. La trasmissione web sarà accessibile nella sezione 'Investitori' del sito web dell'azienda e resterà disponibile in replica per almeno 90 giorni dopo l'evento.
SI-BONE (Nasdaq: SIBN), una empresa de dispositivos médicos enfocada en trastornos sacropélvicos, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 5 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este ese mismo día para discutir los resultados.
Los inversores pueden participar en la llamada conferencia registrándose a través del enlace proporcionado. La transmisión por internet estará disponible en la sección 'Inversores' del sitio web de la compañía y podrá verse en repetición durante al menos 90 días después del evento.
SI-BONE (나스닥: SIBN)은 천장골 장애에 중점을 둔 의료기기 회사로, 2025년 1분기 재무실적 발표를 2025년 5월 5일 장 마감 후에 예정하고 있습니다. 같은 날 오후 1시 30분 태평양 표준시(PST) / 오후 4시 30분 동부 표준시(EST)에 실적을 논의하는 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 제공된 링크를 통해 등록하여 컨퍼런스 콜에 참여할 수 있습니다. 웹캐스트는 회사 웹사이트의 '투자자' 섹션에서 시청할 수 있으며, 행사 후 최소 90일간 다시보기로 제공됩니다.
SI-BONE (Nasdaq : SIBN), une entreprise de dispositifs médicaux spécialisée dans les troubles sacropelviens, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 5 mai 2025, après la clôture des marchés. La société tiendra une conférence téléphonique à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour pour discuter des résultats.
Les investisseurs peuvent participer à la conférence téléphonique en s'inscrivant via le lien fourni. La diffusion en direct sera accessible dans la section « Investisseurs » du site web de l'entreprise et restera disponible en replay pendant au moins 90 jours après l'événement.
SI-BONE (Nasdaq: SIBN), ein Medizintechnikunternehmen, das sich auf sakropelvine Erkrankungen spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 5. Mai 2025 nach Börsenschluss geplant. Am selben Tag findet um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Östlicher Zeit eine Telefonkonferenz zur Besprechung der Ergebnisse statt.
Investoren können an der Telefonkonferenz teilnehmen, indem sie sich über den bereitgestellten Link registrieren. Das Webcast ist über den Bereich „Investoren“ auf der Unternehmenswebsite zugänglich und wird mindestens 90 Tage nach der Veranstaltung als Aufzeichnung verfügbar sein.
- None.
- None.
SANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first quarter of 2025 after market close on Monday, May 5, 2025. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by registering at this link: https://edge.media-server.com/mmc/p/ueassh6s. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.
About SI-BONE, Inc.
SI-BONE (NASDAQ: SIBN) is a global leader in developing unique technologies for surgical treatment of sacropelvic disorders. Since pioneering minimally invasive SI joint surgery in 2009, SI-BONE has supported over 4,300 physicians in performing a total of over 115,000 procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 160 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, sacropelvic fixation and pelvic trauma.
For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.
iFuse Bedrock Granite, iFuse TORQ, iFuse TORQ TNT, SI-BONE, and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2025 SI-BONE, Inc. All Rights Reserved.
Investor Contact: Saqib Iqbal investors@si-bone.com
FAQ
When will SI-BONE (SIBN) release Q1 2025 earnings?
What time is SI-BONE's (SIBN) Q1 2025 earnings call?
How can investors access SI-BONE's (SIBN) Q1 2025 earnings call?
How long will SI-BONE's (SIBN) Q1 2025 earnings webcast be available for replay?
